Adaptimmune Therapeutics
ADAP
#9424
Rank
A$96.31 M
Marketcap
$0.37
Share price
-12.60%
Change (1 day)
-81.91%
Change (1 year)

Earnings for Adaptimmune Therapeutics (ADAP)

Earnings in 2024 (TTM): -A$0.11 Billion

According to Adaptimmune Therapeutics's latest financial reports the company's current earnings are A$0.17 Billion. , an increase over its 2023 earnings that were of -A$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Adaptimmune Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.11 Billion-41.87%
2023 -A$0.19 Billion-30.65%
2022 -A$0.28 Billion-0.36%
2021 -A$0.28 Billion21.62%
2020 -A$0.23 Billion-4.55%
2019 -A$0.24 Billion69%
2018 -A$0.14 Billion-7.47%
2017 -A$0.15 Billion24.71%
2016 -A$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.27 Billion 140.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$12.7 Million-88.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.43 Billion 286.58%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
A$1.13 B-1,145.88%๐Ÿ‡บ๐Ÿ‡ธ USA